EcoDrugPlus

Transthyretin

Ensembl ID : ENSCSEG00000002182
Gene Symbol: TTR
3 Cross references
180 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSCSEG00000006405
Gene Symbol: TPH1
3 Cross references
202 Possible Orthologues:

Tubulin Alpha Chain-Like

Ensembl ID : ENSCSEG00000004061
Gene Symbol: LOC103391677
3 Cross references
158 Possible Orthologues:

Tubulin Beta Chain-Like

Ensembl ID : ENSCSEG00000012670
Gene Symbol: LOC103393554
2 Cross references
178 Possible Orthologues:

Tubulin Beta Chain-Like

Ensembl ID : ENSCSEG00000020132
Gene Symbol: LOC103393868
2 Cross references
193 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSCSEG00000002605
Gene Symbol: TP53
2 Cross references
231 Possible Orthologues:

Type-2 Angiotensin Ii Receptor

Ensembl ID : ENSCSEG00000018029
Gene Symbol: LOC103391362
3 Cross references
189 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSCSEG00000016648
Gene Symbol: TYR
4 Cross references
196 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSCSEG00000018726
Gene Symbol: TYR
3 Cross references
203 Possible Orthologues:

Tyrosine 3-Monooxygenase

Ensembl ID : ENSCSEG00000008767
Gene Symbol: LOC103380366
3 Cross references
188 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSCSEG00000021087
Gene Symbol: TYK2
3 Cross references
196 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSCSEG00000018824
Gene Symbol: TIE1
3 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).